Finfeed Archived Feb 15, 2021
Creso Pharma (ASX: CPH) has negotiated a distribution agreement with leading nutritional supplements company, Route2 Pharm Pvt Ltd
Get expert stock analysis direct in your inbox
Join OurMailing List